Nancy A. Nardone

493 total citations
9 papers, 395 citations indexed

About

Nancy A. Nardone is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Nancy A. Nardone has authored 9 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Physiology. Recurrent topics in Nancy A. Nardone's work include Pancreatic function and diabetes (6 papers), Receptor Mechanisms and Signaling (4 papers) and Adipose Tissue and Metabolism (4 papers). Nancy A. Nardone is often cited by papers focused on Pancreatic function and diabetes (6 papers), Receptor Mechanisms and Signaling (4 papers) and Adipose Tissue and Metabolism (4 papers). Nancy A. Nardone collaborates with scholars based in United States and United Kingdom. Nancy A. Nardone's co-authors include Ralph W. Stevenson, Diane M. Hargrove, Dan E. Berkowitz, Richard M. Smiley, David T. Price, David K. Kreutter, Robert T. Fremeau, Debra A. Schwinn, E. Michael Gibbs and Janice C. Parker and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Nancy A. Nardone

9 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy A. Nardone United States 9 242 161 116 91 55 9 395
Sumio Shima Japan 13 208 0.9× 99 0.6× 55 0.5× 179 2.0× 102 1.9× 41 433
Tae Seok Oh South Korea 12 146 0.6× 180 1.1× 50 0.4× 51 0.6× 19 0.3× 28 436
B. J. Parsons United Kingdom 12 200 0.8× 103 0.6× 47 0.4× 60 0.7× 65 1.2× 22 428
Janet M. Ledingham New Zealand 13 125 0.5× 106 0.7× 47 0.4× 74 0.8× 24 0.4× 40 459
Tonya M. Dixon United States 6 222 0.9× 143 0.9× 89 0.8× 385 4.2× 84 1.5× 6 660
Klaus-Dieter Schultz Germany 5 193 0.8× 254 1.6× 35 0.3× 45 0.5× 67 1.2× 6 465
Adi Drori Israel 10 90 0.4× 110 0.7× 118 1.0× 109 1.2× 65 1.2× 13 446
Sabrina Serpillon France 5 169 0.7× 170 1.1× 27 0.2× 41 0.5× 26 0.5× 8 366
Margaret E. M. Tolbert United States 6 311 1.3× 176 1.1× 160 1.4× 64 0.7× 122 2.2× 6 569
W G Strickland United States 11 206 0.9× 112 0.7× 121 1.0× 125 1.4× 37 0.7× 12 419

Countries citing papers authored by Nancy A. Nardone

Since Specialization
Citations

This map shows the geographic impact of Nancy A. Nardone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy A. Nardone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy A. Nardone more than expected).

Fields of papers citing papers by Nancy A. Nardone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy A. Nardone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy A. Nardone. The network helps show where Nancy A. Nardone may publish in the future.

Co-authorship network of co-authors of Nancy A. Nardone

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy A. Nardone. A scholar is included among the top collaborators of Nancy A. Nardone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy A. Nardone. Nancy A. Nardone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gutteridge, Alex, J. Michael Rukstalis, Daniel Ziemek, et al.. (2013). Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning. PLoS ONE. 8(2). e56024–e56024. 12 indexed citations
2.
Lafontaine, Jennifer, John R. Hadcock, Diane M. Hargrove, et al.. (2007). Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 17(18). 5245–5250. 14 indexed citations
3.
Dow, Robert L., Ernest S. Paight, John R. Hadcock, et al.. (2004). Potent and selective, sulfamide-based human β3-adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(12). 3235–3240. 13 indexed citations
4.
Brozinick, Joseph T., Scott C. McCoid, Thomas Reynolds, et al.. (2001). GLUT4 Overexpression in db/db Mice Dose-Dependently Ameliorates Diabetes But Is Not a Lifelong Cure. Diabetes. 50(3). 593–600. 65 indexed citations
5.
Parker, Janice C., Maria A. VanVolkenburg, Nancy A. Nardone, Diane M. Hargrove, & Kim Andrews. (1997). Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase III. Biochemical and Biophysical Research Communications. 236(3). 665–669. 25 indexed citations
6.
Hargrove, Diane M., et al.. (1996). Comparison of the glucose dependency of glucagon-like peptide-1(7–37) and glyburide in vitro and in vivo. Metabolism. 45(3). 404–409. 14 indexed citations
7.
Berkowitz, Dan E., Nancy A. Nardone, Richard M. Smiley, et al.. (1995). Distribution of β3-adrenoceptor mRNA in human tissues. European Journal of Pharmacology Molecular Pharmacology. 289(2). 223–228. 134 indexed citations
8.
Hargrove, Diane M., et al.. (1995). Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration. Metabolism. 44(9). 1231–1237. 30 indexed citations
9.
Treadway, Judith L., Nancy A. Nardone, R. Kirk McPherson, et al.. (1994). Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.. Journal of Biological Chemistry. 269(47). 29956–29961. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026